Related Experiment Video
Updated: Jul 10, 2026

Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9
Published on: January 3, 2015
Risk of developing a mitochondrial DNA deletion disorder
Patrick F Chinnery1, Salvatore DiMauro, Sara Shanske
1Neurology, University of Newcastle upon Tyne, Newcastle upon Tyne, UK. P.F.Chinnery@ncl.ac.uk
Background:
Pathogenic mitochondrial DNA (mtDNA) mutations are found in at least one in 8000 individuals. No effective treatment for mtDNA disorders is available, making disease prevention important. Many patients with mtDNA disease harbour a single pathogenic mtDNA deletion, but the risk factors for new cases and disease recurrence are not known.
Methods:
We did a multicentre study of 226 families in which a single mtDNA deletion had been identified in the proband, including patients with chronic progressive external ophthalmoplegia, Kearns Sayre syndrome, or Pearson's syndrome. We studied the relation between maternal age and the risk of unaffected mothers having an affected child, and determined the recurrence risks among the siblings and offspring of affected individuals.
Findings:
We noted no relation between maternal age and the risk of unaffected mothers having children with an mtDNA deletion disorder. None of the 251 siblings of the index cases developed clinical features of mtDNA disease. Risk of recurrence among the offspring of affected women was 4.11% (95% CI 0.86-11.54, or one in 117 to one in nine births). Only one of the mothers who had an affected child had a duplication of mtDNA in skeletal muscle.
Interpretation:
Unlike nuclear chromosomal rearrangements, incidence of mtDNA deletion disorders does not increase with maternal age, and unaffected mothers are unlikely to have more than one affected child. Affected women were previously thought to have a negligible chance of having clinically affected offspring, but the actual risk is, on average, about one in 24 births.
Insights
Mitochondrial DNA (mtDNA) deletion disorders do not increase with maternal age. Affected women have a 1 in 24 risk of passing on mtDNA deletion disorders to their offspring.
Area of Science:
- Genetics
- Mitochondrial Biology
- Human Disease
Background:
- Pathogenic mitochondrial DNA (mtDNA) mutations affect at least 1 in 8000 individuals.
- Currently, no effective treatments exist for mtDNA disorders, emphasizing the importance of disease prevention.
- Many patients have a single pathogenic mtDNA deletion, but risk factors for new cases and recurrence are unknown.
Purpose of the Study:
- To investigate the relationship between maternal age and the risk of unaffected mothers having children with mtDNA deletion disorders.
- To determine recurrence risks of mtDNA deletion disorders among siblings and offspring of affected individuals.
Main Methods:
- A multicenter study involving 226 families with a proband identified with a single mtDNA deletion.
- Included patients with chronic progressive external ophthalmoplegia, Kearns-Sayre syndrome, or Pearson's syndrome.
- Analyzed the association between maternal age and the risk of affected offspring, and calculated recurrence risks.
Main Results:
- No correlation was found between maternal age and the risk of unaffected mothers having children with mtDNA deletion disorders.
- None of the 251 siblings of index cases developed clinical features of mtDNA disease.
- The risk of recurrence among offspring of affected women was 4.11% (approximately 1 in 24 births).
Conclusions:
- The incidence of mtDNA deletion disorders is not influenced by maternal age, unlike nuclear chromosomal rearrangements.
- Unaffected mothers are unlikely to have more than one child with an mtDNA deletion disorder.
- The risk of affected women having clinically affected offspring is approximately 1 in 24, a higher risk than previously assumed.
More Related Videos
Related Concept Videos
CRISPR
DNA Damage can Stall the Cell Cycle
Restarting Stalled Replication Forks
Gene Conversion
Genome Copying Errors
DNA Damage Can Stall the Cell Cycle

